USITC Opens Section 337 Probe Into Medical Imaging Devices
Washington, D.C. | January 29, 2026 — The U.S. International Trade Commission (USITC) has formally instituted a Section 337...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Washington, D.C. | January 29, 2026 — The U.S. International Trade Commission (USITC) has formally instituted a Section 337...
BAGSVAERD, DENMARK | December 31, 2025 — Novo Nordisk announced that China’s Supreme People’s Court has upheld the validity...
SALT LAKE CITY, December 29, 2025 — Co-Diagnostics announced that the Australian Patent Office has granted a key patent...
SYDNEY, Australia, December 17, 2025 — Envoy Medical, Inc. has been granted a new Australian patent for its innovative...
London, UK – November 3, 2025 Actimed Therapeutics Ltd, a UK-based clinical-stage specialty pharmaceutical company, has announced the grant...
